Contributor

Fauad Hasan

Chief Executive Officer, Bonti

Fauad Hasan, CEO of Bonti, Inc., is an accomplished biopharmaceutical leader that founded Bonti, a clinical stage biotechnology company developing a next generation neurotoxin for patients with unmet needs. He previously served as the strategic and technical lead for neurotoxin programs at Allergan.